IL37 and autoimmune thrombocytopenic purpura: Moreover, IL-37 exerts its anti-inflammatory effects on monocytes/macrophages in ITP patients by the downregulation of the phosphorylation in the MAPK, AKT and NF-κB signaling pathway.